Treatment-shortening regimens for tuberculosis: updates and future priorities

Treatment-shortening regimens for tuberculosis: updates and future priorities

In the past 2 years, remarkable advances have been made in shortening tuberculosis (TB) treatment. In particular, four clinical trials (Study 31/A5349, Nix-TB, ZeNix and TB-PRACTECAL) have provided evidence of the efficacy of regimens based on new and repurposed drugs: the 4-month regimen for drug-s...

Full description

Bibliographic Details
Main Authors:	Francesca Saluzzo, Victor Abiola Adepoju, Raquel Duarte, Christoph Lange, Patrick P.J. Phillips
Format:	Article
Language:	English
Published:	European Respiratory Society 2023-09-01
Series:	Breathe
Online Access:	http://breathe.ersjournals.com/content/19/3/230028.full

Similar Items

Mind the gap. Rolling out new drug resistant tuberculosis regimens with limited diagnostic tools
by: Francesca Saluzzo, et al.
Published: (2023-08-01)

Principles for designing future regimens for multidrug-resistant tuberculosis
by: Grania Brigden, et al.
Published: (2014-01-01)

Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens
by: Nicholas D. Walter, et al.
Published: (2021-05-01)

Treatment for tuberculosis due to sensitive strains: To shorten or not to shorten?
by: Katerina Manika, et al.
Published: (2023-01-01)

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.
by: Emily A Kendall, et al.
Published: (2017-01-01)

New anti-tuberculosis drugs and regimens: 2015 update
by: Lia D'Ambrosio, et al.
Published: (2015-05-01)

Shortening Tuberculosis treatment schedules in children
by: Katharine Barnes
Published: (2022-04-01)

Shortening and metatony in the Lithuanian future
by: Frederik Kortlandt
Published: (2011-11-01)

Stocking Practices of Anti-Tuberculosis Medications among Community Pharmacists and Patent Proprietary Medicine Vendors in Two States in Nigeria
by: Victor Abiola Adepoju, et al.
Published: (2023-02-01)

Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
by: Rajendra Prasad, et al.
Published: (2017-01-01)

Rethinking Public Private Mix (PPM) Performance in the Tuberculosis Program: How Is Care Seeking Impacting This Model in High TB Burden Countries?
by: Victor Abiola Adepoju, et al.
Published: (2022-07-01)

Acute shortening and angulation for complex open fractures: an updated perspective
by: Sarah N. Pierrie, MD, et al.
Published: (2023-07-01)

HIV Infection Is Associated with Shortened Telomere Length in Ugandans with Suspected Tuberculosis.
by: Elizabeth Auld, et al.
Published: (2016-01-01)

Targeting the Mycobacterium tuberculosis Stringent Response as a Strategy for Shortening Tuberculosis Treatment
by: Carina Danchik, et al.
Published: (2021-10-01)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
by: Emanuele Pontali, et al.
Published: (2019-05-01)

Tuberculosis management and referral practices among traditional medicine practitioners in Lagos, Nigeria
by: Victor Abiola Adepoju, et al.
Published: (2023-03-01)

Knowledge of International Standards for Tuberculosis Care among Private Non-NTP Providers in Lagos, Nigeria: A Cross-Sectional Study
by: Victor Abiola Adepoju, et al.
Published: (2022-08-01)

Initial steroid regimen in idiopathic nephrotic syndrome can be shortened based on duration to first remission
by: Hee Sun Baek, et al.
Published: (2015-06-01)

Tuberculosis: current challenges and beyond
by: Raquel Villar-Hernández, et al.
Published: (2023-03-01)

Lymph node dissection effectively shortens the course of anti-tuberculosis treatment
by: Qibin Liu, et al.
Published: (2023-12-01)

Advantages of short-course rifamycin-based regimens for latent tuberculosis infection: an updated network meta-analysis
by: Tzu-Rong Peng, et al.
Published: (2022-06-01)

A Comparative Analysis of Patient Profiles and Health Service Utilization between Patent Medicine Vendors and Community Pharmacists in Nigeria
by: Victor Abiola Adepoju, et al.
Published: (2023-09-01)

Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR]
by: Liang Fu, et al.
Published: (2023-11-01)

Efficacy and safety of bedaquiline containing regimens in patients of drug-resistant tuberculosis: An updated systematic review and meta-analysis
by: Obaid Ur Rehman, et al.
Published: (2024-02-01)

Patterns of Presentation of Drug-Resistant Tuberculosis in Nigeria: A Retrospective File Review
by: Olanrewaju Oladimeji, et al.
Published: (2022-08-01)

Ending the TB pandemic: the urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council
by: Victor Abiola Adepoju, et al.
Published: (2023-09-01)

A comparison of clinical development pathways to advance tuberculosis regimen development
by: V. Chang, et al.
Published: (2022-12-01)

Optimizing (O) rifapentine-based (RI) regimen and shortening (EN) the treatment of drug-susceptible tuberculosis (T) (ORIENT) using an adaptive seamless design: study protocol of a multicenter randomized controlled trial
by: Zhen Feng, et al.
Published: (2023-05-01)

Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens.
by: Maral Budak, et al.
Published: (2023-06-01)

Crossroads : environmental priorities for the future /
Published: (1988)

Prevention of blindness and priorities for the future
by: West Sheila, et al.
Published: (2001-01-01)

Advantages and Challenges of Tailored Regimens for Drug-Resistant Tuberculosis: A StopTB Italia Look into the Future
by: Riccardi N, et al.
Published: (2020-08-01)

Myocardial Postsystolic Shortening and Early Systolic Lengthening: Current Status and Future Directions
by: Philip Brainin
Published: (2021-08-01)

Light regimen on health and growth of broilers: an update review
by: Yujun Wu, et al.
Published: (2022-01-01)

Do private health providers adhere to National Tuberculosis Guideline while assigning treatment outcome? Findings from a lower middle-income country
by: Victor Abiola Adepoju, et al.
Published: (2022-09-01)

Letter to the Editor of Anales de Pediatría (Barc) about the work of Salinas-Salvador et al. “Retrospective study on the effectiveness and safety of the shortened 5- to 7-day antibiotic regimen for acute streptococcal pharyngotonsillitis compared to the classic 10-day regimen”
by: Miguel Ángel Zafra Anta, et al.
Published: (2023-03-01)

Update on cutaneous tuberculosis
by: Maria Fernanda Reis Gavazzoni Dias, et al.
Published: (2014-12-01)

Vowel shortening in persian
by: abasali vafaei
Published: (2000-06-01)

Peculiarities of acronyms and shortenings
by: Dumitru MELENCIUC, et al.
Published: (2008-12-01)

Priority-Aware Actuation Update Scheme in Heterogeneous Industrial Networks
by: Yeunwoong Kyung, et al.
Published: (2024-01-01)